Home > Healthcare > Medical Devices > Therapeutic Devices > Electrical Stimulators Market

Electrical Stimulators Market Trends

Report ID: GMI7752
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Electrical Stimulators Market Trends

The high demand for alternatives to traditional pain management drugs has become a pivotal factor for the promising growth of the electrical stimulators industry.

Many individuals seek alternatives to traditional pain medications due to concerns about side effects, dependency, and potential long-term consequences associated with pharmaceuticals. Whereas the electrical stimulators offer a non-pharmacological and drug-free approach to pain management, propelling the market growth.
Furthermore, technological advancements in electrical stimulators play a pivotal role as a driving factor in the electrical stimulators industry. These advancements contribute to the development of more sophisticated, user-friendly, and effective devices, fostering innovation and expanding the market's capabilities.
For instance, Longest Science & Technology Co., Ltd developed a MStim Sport LGT-232, a smart, wireless Bluetooth connectivity muscle stimulator for athletes and fitness enthusiasts.
These innovations enhance the therapeutic capabilities of electrical stimulators and contribute significantly to the continued growth and acceptance of these devices in diverse healthcare applications.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for electrical stimulators was valued at USD 3.8 billion in 2023 and is estimated to reach USD 8.8 billion by 2032 as they are medical devices that deliver controlled electrical impulses to specific nerves or muscles in the body.

The physiotherapy/pain management segment held a 45.2% market share in 2023 and is projected to reach USD 4.1 billion by 2032 owing to the high scope for customization which is boosting the success rate and adoption of these devices.

The U.S. electrical stimulators market accounted for USD 980.5 million in 2023 and is predicted to witness substantial growth through 2032 attributed to the prevalence of chronic conditions such as chronic pain, neurological disorders, and musculoskeletal issues.The U.S. electrical stimulators market accounted for USD 980.5 million in 2023 and is predicted to witness substantial growth through 2032 attributed to the prevalence of chronic conditions such as chronic pain, neurological disorders, and musculoskeletal issues.

Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, BTL Corporate, Zynex, Inc., HMS Medical Systems, OMRON Corporation, BioMedical Life Systems, HASOMED GmbH, and Saluda Medical Pty Ltd.